In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cantata Pharmaceuticals Inc.

Latest From Cantata Pharmaceuticals Inc.

Prometheus Rebound: Where Weak Patents Can Benefit Pharma

Biotech and pharma companies were disappointed when the Supreme Court limited patent rights surrounding personalized medicine. But the ruling may end up simplifying the path to adoption of targeted therapies by reaffirming a much more critical point: the therapeutic—not the diagnostic—is the dominant partner.

BioPharmaceutical United States

Selected Start-Ups (6/03)

In Vivo briefly summarizes the technologies of these recently founded companies: BaroNova Therapeutics Inc., Cantata Pharmaceuticals Inc., Cellerant Therapeutics Inc., CePep AB, Compound Therapeutics Inc. and Iris AO Inc.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cantata Pharmaceuticals Inc.
  • Senior Management
  • Mark Trusheim, PhD, Pres. & CEO
  • Contact Info
  • Cantata Pharmaceuticals Inc.
    Phone: (617) 225-9009
    300 Technology Sq.
    5th Fl.
    Cambridge, MA 02139